Dr. Christopher B. Wilson | |
University of Washington School of Medicine Immunology ChairmanAppointed: 1999 University of Washington School of Medicine Immunology ProfessorAppointed: 1989 University of Washington School of Medicine Pediatrics ProfessorAppointed: 1979 |  |
QualificationsM.D., Stanford University, School Of Medicine, Los Angeles, 1972. Further training, Stanford University, School Of Medicine, Pediatrics. Further training, Stanford University, School Of Medicine, Infectious Diseases and Immunology. Undergraduate, summa cum laude, Stanford University, School Of Medicine, Biological Sciences. Expertise and Research InterestsOne major focus of work in the laboratory is the elucidation of molecular mechanisms by which functional differences between naïve and memory/effector T cells are imposed, thereby allowing them to exhibit fixed and heritable patterns of effector functions. These studies helped to define mechanisms by which interferon- g is differentially expressed in T cells, and identified a strong association between reduced DNA methylation within the interferon-g locus and capacity of T cells to produce interferon-g. The latter studies provided early evidence suggesting that programs of T cell effector function are imposed in part by epigenetic mechanisms. To address this question directly, his laboratory has created mice in which DNA methyltransferase l is ablated conditionally at different stages of T cell development. Ongoing studies support the notion that DNA methylation differentially modulates gene expression and thereby affects developmental fate and cytokine production in T-lineage cells. A second focus of work addresses mechanisms governing the development of immunity following primary infection, in particular with the intracellular pathogens Listeria monocytogenes and herpes simplex virus. We are particularly interested in the role of microbial immune evasion strategies in the biology of the infection. To explore how the innate immune system senses microbial invasion and alerts the adaptive immune system during the primary immune response, his laboratory is also exploring the specificity and mechanisms by which Toll-like receptors contribute. These studies have helped to define structural and combinatorial mechanisms that determine the specificity of Toll-like receptor recognition. KeywordsCOS Keywords:Biotechnology, Bone Marrow, Cell Biology, Gene Expression, Gene Regulation, Genes, Genetic Diseases, Genetics, Immunization, Immunobiology, Immunology, Immunotherapy, Inflammation, Lymphocytes, Pediatrics, Transgenic Animals, Transgenics.Additional Terms:Biotechnology, Blood, Blood Cells, Bone Marrow, Cell Biology, Gastrointestinal System, Gene Expression, Gene Regulation, Genes, Genetic Diseases, Genetics, Gi Tract Biology, Gi Tract Disease, Hematopoiesis, Immunobiology, Immunology, Immunotherapy, Infectious Diseases, Inflammation, Lymphocytes, Lymphoid Organs, Lymphopoie, Macrophages, Pediatrics, Respiratory Biology, White Cells.MembershipsAmerican Association for the Advancement of Science American Association of Immunologists American Society for Clinical Investigation Infectious Diseases Society of America Publications- Perez-Melgosa M, Ochs HD, Linsley PS, Laman JD, van Meurs M, Flavell RA, Ernst RK, Miller SI, Wilson CB, Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine, European Journal of Immunology, 31(8), 2373-81, August 2001
 - Wolfer A, Bakker T, Wilson A, Nicolas M, Ioannidis V, Littman DR, Wilson CB, Held W, MacDonald HR, Radtke F, Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development, 2(3), 235-41, March 2001
 - Edelmann KH, Wilson CB, Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection, Journal of Virology, 75(2), 612-21, Jan 2001
 - Hajjar AM, O'Mahony DS, Ozinsky A, Underhill DM, Aderem A, Klebanoff SJ, Wilson CB, Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin, Journal of Immunology, 166(1), 15-9, 2001
 - Jackson-Grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G, Dausman J, Lee P, Wilson C, Lander E, Jaenisch R, Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation, Nature Genetics, 27(1), 31-9, Jan 2001
 - Skeiky YA, Ovendale PJ, Jen S, Alderson MR, Dillon DC, Smith S, Wilson CB, Orme IM, Reed SG, Campos-Neto A, T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection, Journal of Immunology, 165(12), 7140-9, 2000
 - Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A, The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors, Proceedings of the National Academy of Sciences (USA), 97(25), 13766-71, 2000
 - Perez-Melgosa M, Hollenbaugh D, Wilson CB, Cutting edge: CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens., Journal of Immunology, 163(3), 1123-7, 1 Aug 1999
 - Holterman AX, Rogers K, Edelmann K, Koelle DM, Corey L, Wilson CB, An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection, Journal of Virology, 73(3), 2058-63, March 1999
 - Alaniz RC, Thomas SA, Perez-Melgosa M, Mueller K, Farr AG, Palmiter RD, Wilson CB, Dopamine beta-hydroxylase deficiency impairs cellular immunity, Proceedings of the National Academy of Sciences (USA), 96(5), 2274-8, March 1999
 - Sweetser MT, Hoey T, Sun YL, Weaver WM, Price GA, Wilson CB, The roles of nuclear factor of activated T cells and ying-yang 1 in activation-induced expression of the interferon-gamma promoter in T cells., Journal of Biological Chemistry, 273(52), 34775-83, 25 Dec 1998
 - Sweetser MT, Hoey T, Sun YL, Weaver WM, Price GA, Wilson CB, The roles of nuclear factor of activated T cells and ying-yang 1 in activation-induced expression of the interferon-gamma promoter in T cells, Journal of Biological Chemistry, 273(52), 34775-83, December 1998
 - Smith S, Skerrett SJ, Chi EY, Jonas M, Mohler K, Wilson CB, The locus of tumor necrosis factor-alpha action in lung inflammation., American Journal of Respiratory Cell and Molecular Biology, 19(6), 881-91, December 1998
 - Lampe MF, Wilson CB, Bevan MJ, Starnbach MN, Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection, Infection and Immunity, 66(11), 5457-61, November 1998
 - Wilson C B, Embree L J, Schowalter D, Albert R, Aruffo A, Hollenbaugh D, Linsley P, Kay M A, Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration., Journal of Virology, 72(9), 7542-50, September 1998
 - Schowalter D B, Meuse L, Wilson C B, Linsley P S, Kay M A, Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression., Gene Therapy, 4(8), 853-60, August 1997
 - Smith S, Jacobs R F, Wilson C B, Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity., Journal of Pediatrics, 131(1 Pt 1), 16-26, July 1997
 - Kay M A, Meuse L, Gown A M, Linsley P, Hollenbaugh D, Aruffo A, Ochs H D, Wilson C B, Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver., Proceedings of the National Academy of Sciences (USA), 94(9), 4686-91, 29 Apr 1997
 - Penix L A, Sweetser M T, Weaver W M, Hoeffler J P, Kerppola T K, Wilson C B, The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells., Journal of Biological Chemistry, 271(50), 31964-72, 13 Dec 1996
 - Kay M A, Holterman A X, Meuse L, Gown A, Ochs H D, Linsley P S, Wilson C B, Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration., Nature Genetics, 11(2), 191-7, October 1995
 - Wilson C, Kay MA, Immunomodulation to enhance gene therapy [comment, Nat Med, 1(9), 887-9, 1995
 - Nonoyama S, Penix LA, Edwards CP, Lewis DB, Ito S, Aruffo A, Wilson CB, Ochs HD, Diminished expression of CD40 ligand by activated neonatal T cells., Journal of Clinical Investigation, 95(1), 66-75, 1995

Profile DetailsIndividual Expertise profile of Christopher B. Wilson, Copyright Christopher B. Wilson. © COS Expertise TM, 2009, ProQuest LLC All rights reserved. |